SEARCH

SEARCH BY CITATION

References

  • 1
    Stampfer MJ, Ridker PM, Dzau VJ. Markers of malign across the cardiovascular continuum: Interpretation and application. Risk factor criteria. Circulation. 2004;109(25 suppl 1):IV-3IV-5.
  • 2
    Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:26312639.
  • 3
    The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:24132466.
  • 4
    Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358:16821686.
  • 5
    Lewington S, Clarke R, Qizilbash N, et al, for the Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:19031913.
  • 6
    Kikuya M, Hansen TW, Thijs L, et al, on behalf of the International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) Investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;115:21452152.
  • 7
    O'Brien E, Asmar R, Beilin L, et al, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697701.
  • 8
    Izzo JL, Giles TD, Matterson BJ. Defining the syndrome of hypertension. In: IzzoJ, SicaD, BlackH, eds. Hypertension Primer. Philadelphia, PA; Lippincott Williams & Wilkins. In press.
  • 9
    Giles TD, Chatterjee K, Cohn JN, et al. Definition, classification, and staging of the adult cardiomyopathies: A proposal for revision. J Card Fail. 2004;10:68.
  • 10
    Williams B, Lacy PS, Thom SM, et al, on behalf of the CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:12131225.